Buyer Database · Buyer / Distributor · Updated
Imax
Imax is a premium large-format exhibition and licensing network positioning itself as a global box office amplifier, with surging international growth and renewed Wall Street attention as a potential M&A target.
Current mandate
Imax occupies a distinctive position in the exhibition landscape, operating not as a traditional theater chain but as a licensing-focused premium format network. CEO Rich Gelfond has been explicit on this point, telling Wall Street directly: "We are not an exhibitor." That framing has gained traction with analysts. Goldman Sachs analyst Stephen Laszczyk upgraded Imax shares to neutral from sell and raised his price target to $34 from $22, acknowledging that he and his team had "underestimated the degree to which Imax would be able to leverage its industry relationships and programming flexibility to take box office market share, return margins to pre-pandemic levels, and become an attractive potential M&A target." Imax shares rose to $36.83 following the note, reflecting renewed investor confidence in the format's strategic value.
The company's acquisition pattern in recent periods has centered on screen network expansion rather than content rights. Imax with Laser theater installations in Japan, including seven new locations announced for delivery by summer 2023, and earlier additions outside Tokyo and Osaka, illustrate a deliberate push into high-value international markets. Imax box office has surpassed pre-pandemic levels, driven by what Laszczyk described as better indexing, growth in international and local-language box office contribution, expansion of the screen install base, and greater studio-funded marketing. The company is also actively seeking to expand its India network well beyond its current 34 locations, targeting exhibitors in tier-one and broader cities, and is securing filmmaker and studio commitments for Imax-shot projects up to two years in advance.
Material reaches Imax through long-standing studio relationships and direct filmmaker partnerships rather than through open acquisition calls. The company prioritizes a diverse slate of Hollywood and Indian-language titles, and its programming pipeline is built on advance commitments from major studios and filmmakers who design projects specifically for the format. No unsolicited pathway is documented; every tracked deal flows through established studio or production relationships, with Imax functioning as a premium distribution layer on top of existing theatrical releases.
Signature peaks
- Above Pre-Pandemic Levels Post-Pandemic Box Office — Imax box office has surpassed pre-pandemic levels, driven by international growth and studio-funded marketing.
- 34+ Locations India Network Target — Imax is actively seeking to expand its India footprint well beyond its current 34 locations into tier-one and broader cities.
- 7 New Theaters Japan Laser Expansion — Seven new Imax with Laser theaters in Japan were announced for delivery by summer 2023.
Mandate dimensions
- Genre focus
- Not disclosed
- Territory focus
- Not disclosed
- Budget tier (observed)
- Not disclosed
- Access pattern
- Every tracked deal flows through established studio and filmmaker relationships, with Imax securing programming commitments up to two years in advance through direct partnerships with major studios and production companies. No unsolicited pathway is documented; the company's expansion into India and Japan suggests that regional exhibitor and studio partnerships are an emerging route for producers working in those markets.
- Deal structure
- Imax operates on an asset-light, licensing-focused model, partnering with exhibitors and studios through technology licensing agreements and revenue-sharing arrangements rather than acquiring content rights outright. The company functions as a premium distribution layer, with studios and filmmakers committing to Imax-formatted releases in exchange for access to the global Imax screen network.
Recent acquisitions
-
Seven new Imax with laser theaters in Japan
-
Two new locations outside Tokyo and Osaka
Market context
Goldman Sachs upgraded Imax to neutral and raised its price target to $34, calling the company an attractive M&A target with an asset-light model that has surpassed pre-pandemic box office levels.
Imax occupies a distinctive position in the exhibition landscape, operating not as a traditional theater chain but as a licensing-focused premium format network. CEO Rich Gelfond has been explicit on this point, telling Wall Street directly: "We are not an exhibitor." That framing has gained traction with analysts. Goldman Sachs analyst Stephen Laszczyk upgraded Imax shares to neutral from sell and raised his price target to $34 from $22, acknowledging that he and his team had "underestimated the degree to which Imax would be able to leverage its industry relationships and programming flexibility to take box office market share, return margins to pre-pandemic levels, and become an attractive potential M&A target." Imax shares rose to $36.83 following the note, reflecting renewed investor confidence in the format's strategic value.
Common questions about Imax
Does Imax accept unsolicited scripts or pitches?
Imax functions as a premium large-format distribution and licensing network rather than a traditional content acquirer, so no unsolicited submission pathway is documented. The company's programming pipeline is built on advance commitments from major studios and filmmakers who design projects specifically for the Imax format. Every tracked deal flows through established studio or production relationships. Writers and producers are best served by attaching a studio or production partner with an existing Imax relationship before approaching the company.
What budget level does Imax typically work with?
Imax's model is format-driven rather than budget-tier-driven. The company licenses its premium large-format technology to exhibitors and partners with studios on titles shot or formatted for Imax screens. This typically means large-scale studio productions with the resources to shoot on Imax-certified cameras or undertake Imax digital remastering. Budget figures for individual deals are not publicly disclosed in available data, but the format's technical requirements effectively orient the slate toward major studio productions.
What film festivals does Imax source titles from?
Imax's acquisition and programming model is not primarily festival-driven. The company secures filmmaker and studio commitments for Imax-shot projects up to two years in advance, meaning titles are typically locked into the Imax pipeline long before they would appear at a festival. The slate prioritizes Hollywood tentpoles and Indian-language titles sourced through direct studio and filmmaker partnerships. No documented pattern of festival-based acquisition is present in current tracking data.
How do I get my project in front of Imax?
The most documented route is through a major studio or established production company that already has an Imax relationship. Imax secures commitments from filmmakers and studios up to two years in advance, suggesting that the programming conversation happens at the development or early production stage, not at completion. Imax is also expanding its India network and prioritizing Indian-language titles alongside Hollywood fare, which may open pathways for producers working in that market through local exhibitor or studio partnerships.
What genres is Imax currently acquiring?
Imax's stated mandate covers a diverse slate of Hollywood and Indian-language titles, with no single genre restriction documented. In practice, the format's premium positioning and technical requirements favor large-scale action, science fiction, and event films that benefit from the Imax visual and audio experience. The company's international expansion, particularly in Japan and India, signals growing appetite for local-language productions alongside global studio tentpoles. Genre breadth appears to be widening as the international slate grows.
Is Imax currently active in the market?
Yes. Imax box office has surpassed pre-pandemic levels, and Goldman Sachs recently upgraded the stock and raised its price target to $34, citing the company's ability to take box office market share and return margins to pre-pandemic levels. The company is actively expanding its screen network in Japan and India, and is securing filmmaker and studio commitments for Imax-shot projects up to two years out. Analysts have also flagged Imax as an attractive potential M&A target, adding further strategic momentum.
Adjacent buyers in this lane
- Beta Cinema — Beta Cinema is a Munich-based international sales agent specializing in arthouse and literary-adapta
- Starz — Starz is a premium cable and streaming network doubling down on wholly owned scripted drama and inte
- Cineflix Rights — Cineflix Rights is a genre-focused international distributor and co-production financier specializin
- Filmax — Filmax is a Spanish distributor and co-producer with a long track record in genre cinema, currently
Related reading
Match your script to Imax
This is a public snapshot of Imax, kept current from trade-press signals. Inside ScriptMatch, upload your script to see whether Imax fits, why, and exactly how to reach them. Start a card-required 7-day trial or try the no-card buyer-match tool.